Seeking victory
for patients
Your victory is our victory, too.
At Silverback, we’re developing a new kind of therapy – one that can better arm the patient’s immune system against devastating diseases.
At Silverback, we’re developing a new kind of therapy – one that can better arm the patient’s immune system against devastating diseases.
Using our ImmunoTAC platform, we believe it’s possible to develop systemically delivered, tissue-targeted therapeutics for the treatment of cancer, chronic viral infections and other serious diseases.
We’ve designed our new generation of systemically delivered, tissue-targeted therapies to help modulate fundamental disease pathways once thought inaccessible.